Resumo

GARCIA GONZALEZ, Francisco; VIERA ROSALES, Mercy  e  SEDENO CRUZ, Ibis. Mitomycin C in non-penetrating deep sclerostomy. Rev Cubana Oftalmol [online]. 1999, vol.12, n.2, pp. 0-0. ISSN 1561-3070.

We intend in this paper to assess the effectiveness of Mitomycin C as a fibroblastic proliferation inhibitor in the non-penetrating deep sclerostomy (NPDS). This procedure was performed in 40 eyes with primary chronic glaucoma, 20 of them were treated with intraoperative topycal Mitomycin C at 0,5 mg/mL for five minutes and 20 were not applied this drug. They were followed up and assessed one, six and twelve months after the surgery. In the NPDS without mitomycin C group, intraocular pressure was reduced from 27,40 ± 4,76 mmHg to 15,80 ± 2,50 mmHg, but 5 eyes required betablockers compared to a reduction from 27,35 ± 2,91 mmHg to 7,15 ± 1,67 mmHg without betablockers in the NPDS with Mitomycin C group, which presented and extensive, pale, transparent and avascular filtering ampulla and slight complications such as hyphema and dehiscence. The NPDS with mitomycin C was more effective in controlling intraocular pressure and transoperative topycal monodosage of this drug was well tolerated by the patients.

Palavras-chave : MITOMYCIN C [therapeutic use]; SCLEROSTOMY.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )